Cheng Huang

Identification and Experimental Validation of Marker Genes between Diabetes and Alzheimer's Disease

Keshen Li, Xueyi Wen, Cheng Huang, 2022, Oxidative medicine and cellular longevity.

Genome-wide identification of lncRNAs and mRNAs differentially expressed in non-functioning pituitary adenoma and construction of an lncRNA-mRNA co-expression network

N. Zhang, Q. Fang, M. Qiu, 2018, Biology Open.

Circular RNA circ-FoxO3 attenuates blood-brain barrier damage by inducing autophagy during ischemia/reperfusion

C. Tsang, Anding Xu, Jiankun Zang, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Identification of Biomarkers in Intracranial Aneurysm and Their Immune Infiltration Characteristics.

Keshen Li, Cheng Huang, D. Hu, 2022, World neurosurgery.

Linking Diabetes Mellitus with Alzheimer's Disease: Bioinformatics Analysis for the Potential Pathways and Characteristic Genes

Keshen Li, Xueyi Wen, Cheng Huang, 2021, Biochemical Genetics.

A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing

SuSu Zheng, T. Xue, Cheng Huang, 2023, Frontiers in Molecular Biosciences.

Tetrandrine citrate suppresses lung adenocarcinoma growth via SLC7A11/GPX4-mediated ferroptosis

Meng Xu, Di Hu, Xiaocong Mo, 2023, Discover Oncology.

17-DMAG ameliorates neuroinflammation and BBB disruption via SOX5 mediated PI3K/Akt pathway after intracerebral hemorrhage in rats.

Fang Wang, Ling Jin, Jihang Luo, 2023, International immunopharmacology.

The Applications of CircRNA in the Diagnosis and Treatment of Alzheimer's Disease.

Cheng Huang, Juyu Luo, Xueyi Wen, 2024, Molecular Neurobiology.

Exacerbated ischemic brain damage in type 2 diabetes via methylglyoxal-mediated miR-148a-3p decline

Wenhui Huang, Cheng Huang, Xueyi Wen, 2024, BMC medicine.